Status:
UNKNOWN
RFA Using Gradual RF Energy Delivery Mode With Octopus Electrodes
Lead Sponsor:
Seoul National University Hospital
Conditions:
Radiofrequency Ablation
Carcinoma, Hepatocellular
Eligibility:
All Genders
20-85 years
Phase:
NA
Brief Summary
The investigators intend to perform RFA therapy on HCC less than 4 cm in size using octopus electrode, double alternating unipolar high-frequency transmission mode and gradual high-frequency energy lo...
Detailed Description
1. Pre-treatment planning: The detailed plan of radio frequency ablation (RFA) will be implemented in accordance with the routine procedure of image evaluation prior to high frequency implementati...
Eligibility Criteria
Inclusion
- agree to the protocol's requirements and submit a consent form
- 20 years old-85 years old
- Child-Pugh Class A
- among patients with chronic hepatitis or cirrhosis, MDCT or MRI hepatocellular carcinoma of less than 4 cm in size was suspected, and was referred to the radiology department considering clinical RFA therapy as a clinical judgment.
Exclusion
- when the number of malignant HCC is 3 or more
- if the tumor has a maximum size of more than 4 cm
- diffuse infiltrative HCC
- Child-Pugh class B or C
- If there is an invasion of liver vessels due to malignant HCC
- severe coagulopathy
- multiple distant metastasis
- situations where it is very unlikely to obtain appropriate data for research purposes
Key Trial Info
Start Date :
January 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04471272
Start Date
January 6 2020
End Date
December 30 2023
Last Update
March 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea